Dossier
phase III trial
Coverage of phase III trial in the Nexus archive.
- Intensified Pre-Op Chemoradiotherapy Fails in Locally Advanced Rectal Cancer
Adding concurrent irinotecan to capecitabine-based chemoradiotherapy did not improve disease-free survival or other outcomes in a phase III trial for patients with locally advanced rectal cancer.
- Major drugmaker loses $27 billion in market value after failed trial
A major drugmaker lost $27 billion in market value after a heart disease drug failed its Phase III trial, as announced by two companies on Thursday.